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Babesiosis in
Fairfield County,
Connecticut 
To the Editor: Human babesiosis,
caused by Babesia microti, was ini-
tially described in the eastern United
States in 1970 in a woman vacation-
ing on Nantucket Island,
Massachusetts (1). With few excep-
tions, almost all subsequent cases
were recorded from islands in the
northeastern United States and Cape
Cod, Massachusetts (2), until this ill-
ness was diagnosed in 13 patients liv-
ing in New London County in south-
eastern Connecticut (3,4). B. microti
was isolated from white-footed mice,
Peromyscus leucopus, captured from
1988 to 1990 in the yards of patients.
Babesiosis also was diagnosed in per-
sons living in Wisconsin (5) and in
New Jersey (6) who acquired the
organism locally.  The number of
cases of babesiosis reported by health
departments on their Web sites and by
personal communication in Massa-
chusetts, Rhode Island, and New York
State, was 330 from 1988 to 2002,
121 from 1994 to 2002, and 542 from
1986 to 2001, respectively.  The num-
ber of cases reported by the New York
City Health Department from 1991 to
2000 was 75.
From 1991 to 2000, babesiosis was
diagnosed in 230 persons residing in
New London County and adjacent
Middlesex County, Connecticut (7).
Fifty-three additional cases were
reported in five other counties in
Connecticut, but epidemiologic data
did not indicate that these infections
likely were acquired within
Connecticut. We now note a new and
distinct geographic focus by reporting
the isolation of B. microti from
rodents captured in the yards of two
patients in whom babesiosis was diag-
nosed at Greenwich Hospital in 2002.
These patients lived in Greenwich,
Connecticut, which is located in
Fairfield County in the extreme south-
western part of the state. Neither
patient had traveled outside of the
immediate area of Greenwich,
Connecticut, before onset of illness.
We also trapped rodents in the yards
of two additional patients in whom
babesiosis was diagnosed. These two
patients had traveled to Rhode Island
shortly before becoming ill. Patients
became ill from June 23 to July 7,
2002, and none reported a tick bite.
Attempts to trap small mammals
on the properties of the four patients
were made on July 22, 23, and 29,
2002. Rodents were captured in
Sherman box traps baited with peanut
butter and apple. Approximately 0.3
mLof blood was drawn from the heart
of each animal into a syringe coated
with heparin or uncoated. Blood was
kept on ice in the field and then
returned to the laboratory. A 3- to 5-
week-old male Syrian hamster was
injected intraperitoneally with 0.1 mL
of each blood sample.
Blood smears were obtained from
a drop of blood taken from the tail of
each hamster on weeks 3 to 6 after
injection. Blood cells were stained
with Giemsa and examined for B.
microti at a magnification of 1,008x.
Hamsters were considered uninfected
when no parasites were found in 75
fields of stained erythrocytes.  
B. microti was isolated from
rodents captured at the residences of
two of the patients who did not travel
outside of the Greenwich area 6
weeks before onset of illness. Blood
from two of three white-footed mice
and from the two eastern chipmunks,
Tamias striatus, captured in the yards
of the patients, produced infections in
injected hamsters. Infections did not
develop in hamsters injected with
blood from 10 white-footed mice cap-
tured at the residences of two patients
who visited Wakefield and Charles-
town, Rhode Island, shortly before
becoming ill.
B. microti is prevalent in rodent
populations in Greenwich, Connec-
ticut, and causes human disease.
Establishing evidence of B. microti in
rodents and documenting this proto-
zoan parasite as the cause of human
disease in Greenwich are important.
Relatively high populations of the
vector tick, Ixodes scapularis, are
present in Greenwich and nearby
towns. In 2002, the health depart-
ments of Greenwich, Stamford, New
Canaan, and Darien submitted 1,671
I. scapularis ticks removed from per-
sons to the Connecticut Agricultural
Experiment Station for identification
and testing for Borrelia burgdorferi.
Two hundred and thirty cases of Lyme
disease were reported from these four
towns in 2002 (Connecticut
Department of Public Health, unpub.
data). With such extensive human
exposure to ticks and a relatively large
number of Lyme disease cases in
these four towns and elsewhere in
Fairfield County, the number of cases
of babesiosis is likely to increase
appreciably in the future.
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B. microti has been transmitted
through blood transfusion in Connec-
ticut (8).  Blood collection agencies in
southwestern Connecticut and adja-
cent Westchester County, New York,
should be aware of the possibility that
blood donors could be infected with
this pathogen. Physicians should also
be alert to the possibility that patients
could be coinfected with the etiologic
agents of Lyme disease or human
granulocytic ehrlichiosis. Some
patients in whom Lyme disease was
diagnosed have been simultaneously
infected with B. microti (9,10).
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Migratory
Thrombophlebitis
and Acute Q Fever
To the Editor: Q fever is a world-
wide zoonosis particularly common in
some cattle- raising countries such as
Great Britain, France, Spain,
Australia, and Canada (1). Wide-
spread use of diagnostic serologic
tests has led to increasing recognition
of the disease in many other parts of
the world. For example, Q fever has
been recently described in Southeast
Asia (2).
Acute Q fever usually manifests as
a febrile syndrome with hepatic
abnormalities or pneumonia; chronic
Q fever is commonly associated with
endocarditis (3,4). When the disease
manifests with an atypical clinical
picture, diagnosis becomes difficult. 
We describe a patient in whom
Trousseau’s syndrome developed as
the sole manifestation of acute Q
fever. To the best of our knowledge,
this complication has not been found
previously in patients with Q fever.
A 39-year-old, previously healthy
man was admitted to the hospital
because of fever and subcutaneous
painful induration in the legs and
arms. Ten days previously, he had
fever, generalized aches, and malaise.
Forty-eight hours after the onset of
these symptoms, he noticed a painful
induration and redness along the right
calf that spontaneously subsided in a
few days. He remained febrile, and
additional swollen, painful indurated
lesions appeared on his thighs and
arms. Pleuritic chest pain developed,
and he was taken to the emergency
room.
On admission, he was febrile
(38.7°C). A tender, indurated cord, 10
cm long, was felt on the greater
saphenous vein of the right thigh. The
cephalic vein of the left arm and the
basilic vein of the right arm were also
tender and indurated. 
The leukocyte count was
9,800/mm3; hemoglobin 14.5 g/dL,
and platelets 441,000/mm3. The fib-
rinogen levels (385 mg/dL) and pro-
thrombin time (12 s, control 10–14 s)
were normal. The partial thrombo-
plastin time (40 s, control 26–36 s)
was mildly prolonged. Serum aspar-
tate aminotransferase was 75 U/L,
serum alanine aminotransferase was
110 UL, and γ-glutamyltranspeptidase
was 230 U/L. Antibodies to phospho-
lipids (aPL) measured by enzyme-
linked immunosorbent assay were
positive (titer of 95 for antibodies of
class IgG/titer of 19 for antibodies of
class IgM. Results of testing for
tumor-associated antigens, such as
carcinoembryonic antigen, carcinoma
antigen 19-9, prostatic specific anti-
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